These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25089379)

  • 1. Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach.
    Dana D; De S; Rathod P; Davalos AR; Novoa DA; Paroly S; Torres VM; Afzal N; Lankalapalli RS; Rotenberg SA; Chang EJ; Subramaniam G; Kumar S
    Chem Commun (Camb); 2014 Sep; 50(74):10875-8. PubMed ID: 25089379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L.
    Chavarria GE; Horsman MR; Arispe WM; Kumar GD; Chen SE; Strecker TE; Parker EN; Chaplin DJ; Pinney KG; Trawick ML
    Eur J Med Chem; 2012 Dec; 58():568-72. PubMed ID: 23168380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.
    Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S
    Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and
    Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH
    J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L.
    Dos Santos DA; Deobald AM; Cornelio VE; Ávila RMD; Cornea RC; Bernasconi GCR; Paixão MW; Vieira PC; Corrêa AG
    Bioorg Med Chem; 2017 Sep; 25(17):4620-4627. PubMed ID: 28720327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
    Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents.
    Ettari R; Pinto A; Tamborini L; Angelo IC; Grasso S; Zappalà M; Capodicasa N; Yzeiraj L; Gruber E; Aminake MN; Pradel G; Schirmeister T; De Micheli C; Conti P
    ChemMedChem; 2014 Aug; 9(8):1817-25. PubMed ID: 24919925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
    Kishore Kumar GD; Chavarria GE; Charlton-Sevcik AK; Arispe WM; Macdonough MT; Strecker TE; Chen SE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1415-9. PubMed ID: 20089402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
    Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
    Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenoids as novel natural inhibitors of human cathepsin L.
    Ramalho SD; De Sousa LR; Nebo L; Maganhi SH; Caracelli I; Zukerman-Schpector J; Lima MI; Alves MF; Da Silva MF; Fernandes JB; Vieira PC
    Chem Biodivers; 2014 Sep; 11(9):1354-63. PubMed ID: 25238076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
    Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
    Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead.
    Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P
    ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum Mechanics/Molecular Mechanics Studies of the Mechanism of Cysteine Proteases Inhibition by Dipeptidyl Nitroalkenes.
    Arafet K; González FV; Moliner V
    Chemistry; 2020 Feb; 26(9):2002-2012. PubMed ID: 31692123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
    Chowdhury SR; Kennedy S; Zhu K; Mishra R; Chuong P; Nguyen AU; Kathman SG; Statsyuk AV
    Bioorg Med Chem Lett; 2019 Jan; 29(1):36-39. PubMed ID: 30455147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of warheads for design of cysteine protease inhibitors.
    Silva DG; Ribeiro JFR; De Vita D; Cianni L; Franco CH; Freitas-Junior LH; Moraes CB; Rocha JR; Burtoloso ACB; Kenny PW; Leitão A; Montanari CA
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5031-5035. PubMed ID: 29054358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration.
    Fortenberry YM; Brandal S; Bialas RC; Church FC
    Biochim Biophys Acta; 2010 Jun; 1800(6):580-90. PubMed ID: 20230872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanized antibody inhibitor for cathepsin L.
    Shi X; Zhang Y
    Protein Sci; 2020 Sep; 29(9):1924-1930. PubMed ID: 32683733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.